Is It Time to Forget about Huawei?
By Barbara Jorgensen, EETimes
August 21, 2019
Silence is deafening. When asked about the latest delay to a full-scale Huawei trade ban, most chip and component manufactures declined to speak to us. The 90-day extension announced earlier this week by the U.S. Commerce Department purportedly allows suppliers and customers to disengage from the Chinese telecom giant with minimal disruption.
But here's a frightening question to confront: Is it time for the U.S. tech companies to forget about ever seeing another big Huawei design opportunity ever again? The US chip industry is certainly not giving up on China, but Huawei — and by extension China — is inclined to give up on the United States.
The U.S. government, citing national security concerns, has all but barred Huawei products from the United States. American tech companies can still sell to Huawei under a special license, but that’s set to expire in mid-November.
Tech vendors were forced, however, to discuss Huawei during recent earnings conference calls. Out of $70 billion that Huawei spent buying components in 2018, some $11 billion went to U.S. firms including Qualcomm, Intel and Micron Technology.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design